BCX4161

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
12-Week Safety and Efficacy Study of BCX4161 as an Oral Prophylaxis Against HAE AttacksNCT02303626BioCryst PharmaceuticalsPhase 2, Phase 3Completed2016-01Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.